| ||
Italian Clinical Trial for Malignant Pleural Mesothelioma Expands into United ... MesotheliomaHelp.net (blog) NGR-hTNF has been granted Orphan Drug designation – in both the EU and the US – for the treatment of mesothelioma and of liver cancer. In the United States an "orphan disease" status is assigned to a disease or disorder if it affects fewer than 200000 ... See all stories on this topic » | ||
|
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment